Home » Stocks » STE

Steris PLC (STE)

Stock Price: $212.47 USD 0.30 (0.14%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 21.18B
Revenue (ttm) 3.11B
Net Income (ttm) 397.40M
Shares Out 99.68M
EPS (ttm) 4.63
PE Ratio 45.89
Forward PE 32.79
Dividend $1.57
Dividend Yield 0.74%
Trading Day July 23
Last Price $212.47
Previous Close $212.17
Change ($) 0.30
Change (%) 0.14%
Day's Open 213.26
Day's Range 211.73 - 213.89
Day's Volume 353,973
52-Week Range 150.51 - 216.29

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Investors are optimistic about STERIS (STE) owing to strong segmental performance and bullish 2022 outlook.

2 weeks ago - Zacks Investment Research

In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future profit potential. One of the key ways that profit po...

3 weeks ago - Benzinga

Steris (STE) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

STERIS' (STE) acquisition of Cantel Medical will complement and broaden the former's product and service offerings, global reach and customers.

1 month ago - Zacks Investment Research

DUBLIN, IRELAND, June 02, 2021 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of Cantel Medical, a glo...

1 month ago - GlobeNewsWire

Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.

1 month ago - Zacks Investment Research

NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO...

Other stocks mentioned: CMD, SPGI
1 month ago - PRNewsWire

STERIS' (STE) fourth-quarter 2021 revenues improved year over year on robust growth across three segments.

2 months ago - Zacks Investment Research

Shares of Steris (NYSE:STE) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 0.61% over the past year to $1.63, which missed the estimat...

2 months ago - Benzinga

DUBLIN, IRELAND, May 18, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 fourth quarter ended March 31, 2021. Revenue as...

2 months ago - GlobeNewsWire

STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.

2 months ago - Zacks Investment Research

DUBLIN, IRELAND, May 11, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced changes to its Board of Directors. David Lewis, Board member since 2010 has announced...

2 months ago - GlobeNewsWire

DUBLIN, IRELAND, April 27, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 fourth quarter and f...

2 months ago - GlobeNewsWire

Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.

3 months ago - Zacks Investment Research

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

Other stocks mentioned: ALGN, ICLR, PRAH, TDOC, TMO, XRAY
3 months ago - Zacks Investment Research

Investors are optimistic about STERIS (STE) owing to strong segmental performance amid the pandemic and huge growth potential in healthcare and pharmaceutical industries.

3 months ago - Zacks Investment Research

Steris (STE) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cantel...

Other stocks mentioned: CMD
5 months ago - PRNewsWire

STERIS' (STE) third-quarter fiscal 2021 results reflect strong performance by all three of its reporting segments despite the coronavirus-led economic crisis.

5 months ago - Zacks Investment Research

DUBLIN, IRELAND, Feb. 03, 2021 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that Walt Rosebrough, President and CEO, has announced his intention to step down o...

5 months ago - GlobeNewsWire

Steris (STE) delivered earnings and revenue surprises of 10.90% and 1.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Steris (NYSE:STE) moved higher in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 19.31% over the past year to $1.73, which beat the es...

5 months ago - Benzinga

DUBLIN, IRELAND , Feb. 02, 2021 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 third quarter ended December 31, 2020.  Reve...

5 months ago - GlobeNewsWire

Steris (NYSE:STE) will be releasing its next round of earnings this Tuesday, February 02. For all of the relevant information, here is your guide for Tuesday's Q3 earnings announcement.

5 months ago - Benzinga

Within Life Sciences, STERIS (STE) might have registered benefits from pharma customers on growing vaccines, along with a recovery in the Healthcare arm in Q3.

5 months ago - Zacks Investment Research

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

DUBLIN, IRELAND, Jan. 19, 2021 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 third quarter financ...

6 months ago - GlobeNewsWire

Steris is a long-term value creator, which combines organic growth with bolt-on acquisitions. The company started 2021 with a big deal, acquiring Cantel in a multi-billion transaction.

6 months ago - Seeking Alpha

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel Medical Cor...

Other stocks mentioned: CMD
6 months ago - Business Wire

STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.

Other stocks mentioned: CMD
6 months ago - Zacks Investment Research

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors concerning th...

Other stocks mentioned: CMD
6 months ago - PRNewsWire

Shares of Cantel Medical Corp. rose 1.8% in premarket trading Tuesday, after the infection prevention products company announced an agreement to be acquired by Ireland-based Steris PLC in a cash and equ...

Other stocks mentioned: CMD
6 months ago - Market Watch

DUBLIN, IRELAND and LITTLE FALLS, N.J, Jan. 12, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has ...

6 months ago - GlobeNewsWire

DUBLIN, IRELAND, Jan. 07, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company will be publicly webcasting presentations made by Walt Rosebrough, ...

6 months ago - GlobeNewsWire

Steris (STE) reported earnings 30 days ago. What's next for the stock?

7 months ago - Zacks Investment Research

DUBLIN, IRELAND, Nov. 18, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that is has completed the previously announced acquisition of Key Surgical, a portfo...

8 months ago - GlobeNewsWire

3 Best Buys from the Prospering Medical Instruments Industry

Other stocks mentioned: IDXX, TMO
8 months ago - Zacks Investment Research

STERIS plc's (STE) CEO Walter Rosebrough on Q2 2021 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

STERIS plc (STE) CEO Walter Rosebrough on Q2 2021 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

STERIS' (STE) second-quarter fiscal 2021 results reflect strong performance by the Life Sciences and the Applied Sterilization Technologies segments despite the coronavirus-led economic crisis.

8 months ago - Zacks Investment Research

Steris (STE) delivered earnings and revenue surprises of 19.35% and 7.23%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

DUBLIN, IRELAND , Nov. 02, 2020 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 second quarter ended September 30, 2020.  Re...

8 months ago - GlobeNewsWire

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Other stocks mentioned: HSIC, INSP, PACB
8 months ago - Zacks Investment Research

Within Life Sciences, STERIS (STE) might have registered benefit from pharma customers on growing vaccines and biologics businesses in Q2.

8 months ago - Zacks Investment Research

COVID-19 has heightened the demand for companies that specialize in infection control.

Other stocks mentioned: CMD, JNJ
8 months ago - The Motley Fool

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

DUBLIN, IRELAND, Oct. 20, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 second quarter financ...

9 months ago - GlobeNewsWire

Steris (STE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

9 months ago - Zacks Investment Research

Steris PLC STE, +1.18% said Tuesday it has agreed to acquire Key Surgical, a portfolio company of Water Street Healthcare Partners LLC for $850 million. Dublin, Ireland-based Steris expects the deal to ...

9 months ago - Market Watch

DUBLIN, IRELAND, Oct. 06, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase Key Surgical, a portf...

9 months ago - GlobeNewsWire

About STE

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solut... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 1, 1992
CEO
Walter Rosebrough
Employees
13,000
Stock Exchange
NYSE
Ticker Symbol
STE
Full Company Profile

Financial Performance

In 2020, Steris's revenue was $3.11 billion, an increase of 2.53% compared to the previous year's $3.03 billion. Earnings were $397.40 million, a decrease of -2.52%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Steris stock is "Buy." The 12-month stock price forecast is 228.40, which is an increase of 7.50% from the latest price.

Price Target
$228.40
(7.50% upside)
Analyst Consensus: Buy